| PEB0158 | Burden of Human Papillomavirus infection among HIV positive women in North Central Nigeria: A cross sectional study | E-poster | B14 |
| PEB0159 | Prevalence and characteristics of anal papillomavirus infection in a Cohort of HIV-positive men who have sex with men in Lima, Peru | E-poster | B14 |
| PEB0160 | Clinical and laboratory aspects of patients with asymptomatic neurosyphilis and HIV infection treated with ceftriaxone: A retrospective cohort | E-poster | B14 |
| PEB0161 | Integrating HPV testing for cervical cancer screening in WLHIV in Zambia | E-poster | B14 |
| PEB0162 | Dramatic increase of macrolide resistance in Treponema pallidum isolates in Argentina | E-poster | B14 |
| PEB0163 | Incorporation of screening and treatment for sexually transmitted infections into routine care for patients living with HIV in Gaborone, Botswana | E-poster | B14 |
| PEB0164 | Epidemiology of Human Papillomavirus genotypes and prevalence of cervical precancerous lesions among women living with HIV: Results from a pilot cervical cancer screening program in Uganda | E-poster | B14 |
| PEB0165 | Discover study for HIV Pre-Exposure Prophylaxis (PrEP): No evidence of risk compensation in participants taking F/TDF or F/TAF for PrEP through 96 weeks | E-poster | B14 |
| PEB0166 | Anal cytological abnormalities and HPV detection with different primer sets in HIV-positive men in eastern India | E-poster | B14 |
| PEB0167 | Clinical prediction of Chlamydia trachomatis and Neisseria gonorrhea among adolescents and young adults living with HIV in Eswatini | E-poster | B14 |